Profile: PhenoPath Laboratories is a national reference laboratory specializing in immunohistochemistry and in situ hybridization services. We render screening, diagnostic and prognostic testing services to hospitals, physician offices, surgery centers, biopharmaceutical companies and research institutions. Our services include antibodies for IHC & IF, flow cytometry panels, fluorescence in situ hybridization (FISH) probes and PCR. Our KRAS detects the 7 most common codon 12 and 13 KRAS mutations (G12A,G12C,G12D,G12R,G12S,G12V,G13D). Our KRAS mutation status is a key predictor of patient responsiveness to anti-EGFR directed therapies. Our BRAF detects the V600E BRAF activating mutation. The BRAF activation status is a key predictor of patient responsiveness to anti-EGFR directed therapies.

The company was founded in 1997.